Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Letrozole|DRUG: Trastuzumab plus Letrozole|DRUG: Letrozole
Sponsor: Novartis Pharmaceuticals
Collaborators: Roche - Prof. Dr. Jens Huober et al.